Free Trial
→ Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (From Colonial Metals) (Ad)

GSK Q3 Earnings Report

GSK logo
GBX 1,429 -18.00 (-1.24%)
As of 02/21/2025 12:16 PM Eastern
Earnings HistoryForecast

GSK EPS Results

Actual EPS
GBX 49.70
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GSK Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GSK Announcement Details

Quarter
Q3
Date
10/30/2024
Time
Before Market Opens

Conference Call Resources

GSK Earnings Headlines

GSK to sell 500K doses of bird flu vaccines to Canada
February 20 at 10:30 AM | msn.com
GSK Shares Gain Over 17% In 5 Days After Major Jump In Q3 Profits
February 18, 2025 | msn.com
Bill Gates’ is about to mint millionaires (again) with Stargate.
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.
February 22, 2025 | Brownstone Research (Ad)
GSK reports FDA approves Penmenvy 5-in-1 meningococcal vaccine
February 17, 2025 | markets.businessinsider.com
Billionaire’s hedge fund bets big against the GSK share price!
February 17, 2025 | msn.com
GSK’s Penmenvy meningococcal vaccine gains FDA approval
February 17, 2025 | msn.com
See More GSK Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GSK? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GSK and other key companies, straight to your email.

About GSK

GSK (LON:GSK), together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

View GSK Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles